The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension - Forzano, Imma; Mone, Pasquale; Varzideh, Fahimeh; Jankauskas, Stanislovas S.; Kansakar, Urna; De Luca, Antonio; Santulli, Gaetano (Frontiers in Endocrinology, 2022)